Skip navigation
RSS feed for this page
Know something we don't? Submit a conference announcement
Choose Category:

Infectious Diseases meetings & conferences

31 meetings & conferences listed in Infectious Diseases 

16th Annual International Meeting of the Institute of Human Virology
United States

16th Annual International Meeting of the Institute of Human Virology

September 14-17, 2014 Baltimore, Maryland

IHV continues the tradition of engaging world science leaders to share cutting edge research advances - this year focusing on HIV cure, pathogenesis, basic and translational vaccine research, and collective lessons from recent conceptual advances in cancer immunology. 

Physician Researcher, Virologist
EUROGIN 2015 Congress

EUROGIN 2015 Congress

Feb 4-7, 2015 Seville, Spain

The EUROGIN 2015 Congress aims at developing a full review of current scientific developments in the field of cervical cancer and human papillomavirus related diseases, raising the public health profile and increasing the need for responsible health services in this area.

The event endeavors to translate scientific and evidence-based research into clinical practice while highlighting the following aspects:

- Recent advances and updated scientific insights in HPV screening, testing and management

- The impact of HPV and associated cancers on public health

- Strategies to prevent and treat HPV related diseases

- Exchanging information on early detection, new diagnostic and therapeutic procedures and prevention strategies including screening and HPV vaccination

Speakers include international leaders from academic, government and private organizations, representatives of medical and scientific societies, as well as women's health associations who will discuss and exchange ideas on issues relevant to both individuals and public health

Gynecologist, Oncologist, Physician, Physician Researcher, Public Health Expert, Public Health Worker, Public Servant
15th International Symposium on Viral Hepatitis and Liver Diseases (ISVHLD)

15th International Symposium on Viral Hepatitis and Liver Diseases (ISVHLD)

June 26-28, 2015 Berlin, Germany

In June 2015 the 15th International Symposium on Viral Hepatitis and Liver Diseases (ISVHLD) will be held in Berlin, Germany.

ISVHLD has a tradition of 43 years. Initially the focus was on discovery of hepatitis viruses, then it was the development of diagnostic procedures, vaccines, understanding pathophysiology and now therapies. In 2015 will be the time when many of the new direct antiviral agents (DAAs) against hepatitis C will be approved. However public health will become very important to identify the patients in need for therapy and to make these new therapies accessible to all parts of the world. Furthermore we still need to develop better finite therapies for hepatitis B and need to address many more burning issues of global relevance like hepatitis D and E.

This symposium is organized every three years moving around the continents. Basic scientists and clinicians will discuss the most recent advances made against the global health burden caused by all hepatitis viruses. For the first time the symposium will be organized in Germany taking place in its capital Berlin.

Hepatologist, Physician, Physician Researcher, Virologist
2014 Medical Countermeasures Initiative (MCMi) Regulatory Science Symposium
United States

2014 Medical Countermeasures Initiative (MCMi) Regulatory Science Symposium

June 2-3, 2014 FDA Headquarters White Oak Campus Silver Spring, Maryland

On June 2-3, 2014, FDA will host its 3rd public Medical Countermeasures Initiative (MCMi) Regulatory Science Symposium to:

(1) Update stakeholders on FDA’s current MCM activities and recent accomplishments,

(2) Highlight progress of ongoing intramural regulatory science research activities, and

(3) Discuss the future of MCMi regulatory science.

This event is free, and open to the public. Advance registration is required. 

About MCMi

FDA plays a critical role in protecting the United States from chemical, biological, radiological, nuclear, and emerging infectious disease threats. FDA’s responsibility is to ensure that medical countermeasures (MCMs)—such as drugs, vaccines, and diagnostic tests—to counter these threats are safe, effective, and secure.

Physician, Physician Researcher, Public Health Expert, Public Health Worker, Public Servant, Virologist
International Symposium on Minority Health and Health Disparities
United States

International Symposium on Minority Health and Health Disparities

December 1–3, 2014 National Harbor, Maryland

The International Symposium on Minority Health and Health Disparities will convene December 1–3, 2014 in National Harbor, Maryland. Pre-Symposium Training workshops will take place December 1, 2014.

In keeping with the theme of the symposium, "Transdisciplinary Collaborations: Evolving Dimensions of US and Global Health Equity,” the scientific program will highlight the excellence and innovation in basic, translational, and clinical research from the programs supported by the National Institute on Minority Health and Health Disparities (NIMHD). The Symposium has been designed to offer opportunities for sharing research information in areas related to cardiovascular disease, diabetes and obesity, cancer, women's health, mental health, infectious disease, stroke, and behavioral and community health with special emphasis on minority health and health disparities. We invite others who are engaged in clinical, translational, basic science, education, and policy research in minority health and health disparities to join us.

Academic, African American, Behavioral Scientist, Health Services Researcher, Latino/Hispanic, Native American, Nurse, Nurse Researcher, Pacific Islander, Physician, Physician Researcher, Policy Analyst, Public Health Expert, Public Health Worker, Public Servant, Social Scientist
2014 National TB Conference
United States

2014 National TB Conference

June 10-13, 2014 Atlanta, Georgia

As a part of its mission, the National Tuberculosis Controllers Association (NTCA) helps to organize the National TB Conference in Atlanta, Georgia. TB controllers, physicians, nurses, laboratorians, epidemiologists, health educators, and CDC staff share their expertise and experience at this conference.

The title for the 2014 conference is “Sharing the Vision of TB Elimination.” The main conference will be held June 11-13, 2014, at the Grand Hyatt Atlanta in Buckhead Hotel, in Atlanta, Georgia.

Epidemiologist, Nurse, Nurse Researcher, Physician, Physician Researcher, Public Health Expert, Public Health Worker, Public Servant
3rd World Congress on Controversies in the Management of Viral Hepatitis

3rd World Congress on Controversies in the Management of Viral Hepatitis

May1-3, 2014 Berlin, Germany

The large attendance and enthusiastic feedback from the 1st Congress and in particular the 2nd Congress held in Berlin this October, illustrated the need for this unique meeting completely focusing on the needs of the busy clinician caring for HCV and HBV infected patients.

The C-Hep Congress attempts to summarize all the key new data recently presented – and how it might be implemented in routine care of Hepatitis B and C patients. Overviews, state of the art lectures and controversial debates with the outstanding faculty of the top world leaders presenting both pro and con positions challenge and explore the optimal treatment for patients, with emphasis on the appropriate use of new and emerging drugs.

This educational Congress focuses on clinical practices in Viral Hepatitis and benefits not only Hepatologists and Infectious Diseases specialist, but also general practitioners, internists and primary care physicians with a desire to gain knowledge on these exciting advances.

The format includes a significant allocation of time for interactive debates and questions from the audience to each panel of experts. Participants are encouraged to take an active role in the discussions with faculty members which follow each debate, in a unique and open environment.

Hepatologist, Internist, Physician, Primary Care Physician
Amazonian Conference on Emerging and Infectious Diseases
French Guiana

Amazonian Conference on Emerging and Infectious Diseases

26th to September 28th, 2014 Cayenne, French Guiana

Organized by the STRonGer consortium, the Amazonian Conference on Emerging and Infectious Diseases (ACEID) will be held from September 26th to September 28th, 2014 in Cayenne, French Guiana.

Since the late 19th century, tremendous efforts have been made to fight against infectious agents responsible for human diseases. The development of hygiene, including the quality of drinking water, better food, the advent and generalization of vaccination, the widespread use of pesticides as well as antibiotics are only a few steps that led to a drastic reduction of public health burden due to infectious diseases.

However, parasites, bacteria and viruses remain a major cause of human mortality worldwide. New diseases have emerged, others have re-emerged in areas where they had been eradicated or at least controlled, and a few others have seen their geographical distribution dramatically expanded.

In parallel with the emergence of new infectious agents, we have to face an increased resistance of bacteria, parasites and viruses respectively to antibiotics, antiparasitic and antiviral molecules. Lastly, numerous arthropod vectors have developed a resistance to insecticide molecules commonly used for vector control.

Some of these infectious agents and their associated diseases have a huge impact worldwide on public health and socio-economic development. Their control has become a major political and strategic international issue. This has led to increased institutional support of research.

In this context, there is an important need for sharing and disseminating the latest developments in emerging and infectious diseases field within the scientific community. The Amazonian Conference on Emerging and Infectious Diseasesthus aims to get together a broad range of scientists “linking fieldwork, benchside and bedside approaches”.

Attending this conference will be the opportunity to stimulate and strengthen collaborations across fields, and to network with a worldwide interdisciplinary group including researchers and academics, as well as health professionals.


Chikungunya: epidemiological situation, virological & entomological context, public health answers

Diseases at the interface of humans, wildlife and other animals

Dynamics of ID: Tele-epidemiology and spatio-temporal approaches

Ecological factors and climate change in disease emergenceGenetics of insecticide resistance

Infections related to travel and migration

Influenza and other respiratory infections

Innovation in diagnostic tests

Mechanisms of drug resistance

Methods and models of disease surveillance detection and prediction

Molecular epidemiology of malaria

New, emerging and neglected diseases

Omics for pathogen discovery

Omics in drug discovery

Outbreak modeling

Outbreak response and control

Population genetics of parasites and vectors

Tools for detection of resistance

Vector competence

Vector-borne diseases

Epidemiologist, Physician Researcher, Public Health Expert, Public Health Worker, Veterinary Scientist, Virologist
6th International Gamma Delta T-Cell Conference
United States

6th International Gamma Delta T-Cell Conference

May 16 - 18, 2014 University of Illinois at Chicago

We are very pleased to announce that the sixth biennial International Gamma Delta (γδ) T-Cell Conference will be held on May 16-18, 2014 in Chicago, USA. The International γδ T-Cell Conference is held every two years, and is the only forum for presentation and discussion of cutting-edge advances in the basic to translational aspects of γδ T-cell research.

Importantly, there will be a special opening section to celebrate the 30th year anniversary of the discovery of γδ T cells. Several pioneers contributing to the discovery of γδ T cells will for the first time give an historical overview of their discoveries in 1984-1987.

γδ T cells have broad function such as tissue homeostasis/ tissue repair and immune regulation/responses to cancers, inflammation/ autoimmunity, and infections contributing to immune resistance to tuberculosis. Recent studies have continuously made new discoveries about the biology and function of γδ T cells. Translational studies in clinical trials and pre-clinical proof-of- concept investigations continuously explore utility and efficacy of γδ T cell-based immunotherapeutic treatment of cancer patients and nonhuman primates with TB and other infections.

Topics that will be covered in the conference include Historical Overview of γδ T-Cell Discovery; γδ T-Cell Development and Homeostasis; Antigens and Ligands for γδ T Cells; Co-receptors and Co-stimulatory Molecules of γδ T Cells; γδ T Cells and Their Neighbors; γδ T Cells In Infections and Immunity; γδ T Cells In Inflammation, Tissue Repair, and Autoimmunity; γδ T Cells in Cancers; γδ T Cells and Immunotherapy.

We welcome all who have an interest in this very exciting and promising area of biomedical research.

Cell Biologist, Immunologist, Microbiologist, Molecular Biologist, Oncologist, Physician Researcher
Antibiotic Alternatives for the New Millennium
United Kingdom

Antibiotic Alternatives for the New Millennium

Wednesday, 05 November 2014 09:00-Friday, 07 November 2014 17:00 London, United Kingdom

The inexorable rise in the incidence of antibiotic resistance in bacterial pathogens, coupled with the disappointingly low rate of emergence of new,clinically useful antibiotics, has refocused attention on finding alternatives to antibiotic treatments. This event will discuss the potential utility of phages, probiotics, antimicrobial peptides, herbal medicines and immune modulation for treating human and animal disease.

Who Should Attend

From researchers trying to find alternatives to therapies to pharmacists delivering treatments: any one with an interest in antibiotic alternatives would find this event of value.

Clinical Pharmacist, Pharmacist, Pharmacologist, Physician, Physician Researcher, Veterinary Scientist